Dermadenta - Company finances
|
EUR
|
2019
From: 2019-03-28
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|
|
Financial data
|
|||||||
| Sales revenue | 6,695 | 36,975 | 25,425 | 24,335 | 83,074 | 94,675 | 103,372 |
| Profit before tax | -9,333 | 8,174 | 1,864 | 1,037 | 17,561 | 9,939 | -1,117 |
| Net profit | -9,333 | 8,174 | 1,815 | 963 | 17,220 | 9,939 | -1,117 |
| Equity | -8,333 | -160 | 1,655 | 2,619 | 19,912 | 29,852 | 13,735 |
| Liabilities | - | - | - | 20,056 | 4,451 | 4,152 | 2,873 |
| Non-current assets | 35,169 | 30,045 | 24,921 | 19,839 | 16,394 | 16,076 | 12,324 |
| Current assets | 591 | 1,317 | 4,209 | 2,998 | 7,852 | 17,795 | 4,151 |
| Total assets | 35,760 | 31,362 | 29,130 | 22,837 | 24,246 | 33,871 | 16,475 |
|
Taxes paid
|
|||||||
| STI taxes | - | - | - | - | 2,544 | 5,741 | 8,461 |
|
Financial indicators
|
|||||||
| Revenue change y/y | - | +452.3% | -31.2% | -4.3% | +241.4% | +14.0% | +9.2% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -26.1% | 26.1% | 6.2% | 4.2% | 71.0% | 29.3% | -6.8% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | 109.7% | 36.8% | 86.5% | 33.3% | -8.1% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -139.4% | 22.1% | 7.1% | 4.0% | 20.7% | 10.5% | -1.1% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -139.4% | 22.1% | 7.3% | 4.3% | 21.1% | 10.5% | -1.1% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | 7.7 | 0.2 | 0.1 | 0.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 2,678 | 16,433 | 13,265 | 8,691 | 32,158 | 31,558 | 34,457 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Dermadenta - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-04-16 | 2025-04-16 | 426.33 |
| 2023-05-16 | 2023-06-07 | 1.08 |
| 2023-05-02 | 2023-05-07 | 1.08 |
| 2023-04-25 | 2023-04-28 | 1.08 |
| 2023-02-17 | 2023-02-20 | 120.13 |
| 2023-02-06 | 2023-02-08 | 120.13 |
| 2023-01-17 | 2023-02-03 | 120.13 |
Dermadenta - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Dermadenta, MB (code 305097885) is a Small partnership engaged in dental practice care activities. In 2025, the company generated revenue of €103.4K, up 9.2% year on year and 24.4% over two years. However, profitability weakened materially: net profit turned to a loss of €1.1K, compared with a profit of €9.9K in 2024 and €17.2K in 2023. The 2025 profit margin was -1.1%, after 10.5% in 2024 and 20.7% in 2023, showing a clear downward trend in earnings despite continued sales growth. The balance sheet also contracted in 2025, with total assets falling to €16.5K from €33.9K a year earlier. Equity declined to €13.7K, while liabilities were €2.9K, leaving an equity ratio of 83.4% and debt-to-equity of 0.21. Asset turnover was 6.27x, indicating a high level of revenue relative to the asset base. Revenue per employee was €34.5K, while profit per employee was -€372 in 2025.